The present invention provides fully human antibodies that bind to respiratory syncytial virus F protein, compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for preventing fusion of the virus with the cell membrane and preventing cell to cell spread of the virus, thereby providing a means of preventing the infection, or treating a patient suffering from the infection and ameliorating one or more symptoms or complications associated with the viral infection. The antibodies may also be useful for diagnosis of an infection by RSV.un anticuerpo completamente humano aislado o un fragmento de unión al antígeno de este que se une específicamente a la proteínas F del virus respiratorio sincitial (RSV-F)； ácido nucleico que lo codifica, vector que la contiene, célula que contiene el vector, composiciones que la contienen y sus usos.
